The uPA/uPAR system plays an important role in cancer development and progression, especially in favoring migration through the extracellular matrix; however, several other mechanisms might be involved in MM progression, thus proposing the uPA/uPAR system as a candidate therapeutic target [63,64,73]. This evidence concerns the gene PLAUR and Miyoshi myopathy.